Scientists probe mysteries of rare arthritis to unlock new treatments

NCT ID NCT07302074

Summary

This study aims to understand the causes of rare and emerging types of inflammatory arthritis, including those linked to cancer immunotherapies. Researchers will compare tissue samples from 100 people with rare arthritis to samples from people with more common forms like rheumatoid arthritis. The goal is to identify differences that could lead to better, more targeted treatments in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Brest - Hôpital Morvan

    Brest, 29200, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU bordeaux

    Bordeaux, 33404, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.